Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Fidia Spa ( (IT:FDA) ).
Fidia S.p.A. has announced a change in its share capital following the conversion of outstanding convertible bonds into ordinary shares over several transactions carried out between late November and mid-December 2025. As a result, the company’s fully subscribed and paid-in share capital has risen by €750,000 to €9,347,761.90, while the number of ordinary shares has increased from 18,977,312 to 25,298,485, all admitted to trading on Euronext Milan. The updated Articles of Association and the statutory statement certifying the progressive execution of the capital increase have been filed with the Companies Register of Turin, formalizing the strengthened equity structure and expanding the free float for investors.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.15 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in San Mauro Torinese and listed on Euronext Milan, is a global leader in high-performance integrated milling systems, serving primarily the automotive mould-making and aerospace sectors. With more than 50 years of experience and around 135 employees, the group offers end-to-end solutions for the entire milling process, including numerical controls for milling systems, high-speed milling machines and CAM software for complex shapes.
Average Trading Volume: 809,168
Technical Sentiment Signal: Strong Sell
Current Market Cap: €2.35M
See more insights into FDA stock on TipRanks’ Stock Analysis page.